23 related articles for article (PubMed ID: 7017368)
1. Author Correction: On the mechanism of wogonin against acute monocytic leukemia using network pharmacology and experimental validation.
Wang X; Wang Y; Chen J; Wang Q; Liu Z; Yin Y; Yang T; Shen T; Sa Y
Sci Rep; 2024 Jun; 14(1):14531. PubMed ID: 38914691
[No Abstract] [Full Text] [Related]
2. Randomized phase-III study of low-dose cytarabine and etoposide + /- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia.
Schlenk RF; Weber D; Krzykalla J; Kindler T; Wulf G; Hertenstein B; Salih HR; Südhoff T; Krauter J; Martens U; Wessendorf S; Runde V; Tischler HJ; Bentz M; Koller E; Heuser M; Thol F; Benner A; Ganser A; Döhner K; Döhner H
Sci Rep; 2023 Sep; 13(1):14809. PubMed ID: 37684299
[TBL] [Abstract][Full Text] [Related]
3. Etoposide and teniposide in the treatment of acute leukemia.
Björkholm M
Med Oncol Tumor Pharmacother; 1990; 7(1):3-10. PubMed ID: 2187120
[TBL] [Abstract][Full Text] [Related]
4. Effective remission induction of refractory childhood acute nonlymphocytic leukemia by VP-16-213 plus azacitidine.
Look AT; Dahl GV; Kalwinsky D; Senzer N; Mason C; Rivera G
Cancer Treat Rep; 1981; 65(11-12):995-9. PubMed ID: 6170431
[TBL] [Abstract][Full Text] [Related]
5. Combination of high-dose cyclophosphamide, BCNU, and VP-16-213 followed by autologous marrow rescue in the treatment of relapsed leukemia.
Zander AR; Vellekoop L; Spitzer G; Verma DS; Litam J; McCredie KB; Keating M; Hester JP; Dicke KA
Cancer Treat Rep; 1981; 65(5-6):377-81. PubMed ID: 7016323
[TBL] [Abstract][Full Text] [Related]
6. [Initial results with a epipodophyllotoxin derivative VP 16-213 in the treatment of acute leukemia].
Cavalli F; Ryssel HJ; Batz K; Sonntag RW; Brunner KW
Schweiz Med Wochenschr; 1975 Feb; 105(8):250-3. PubMed ID: 1054886
[TBL] [Abstract][Full Text] [Related]
7. [VP 16-213 in the treatment of acute leukemia in childhood].
Esumi N; Arakawa S; Imashuku S
Gan To Kagaku Ryoho; 1983 Mar; 10(3):848-51. PubMed ID: 6576730
[TBL] [Abstract][Full Text] [Related]
8. VP 16-213 and cyclophosphamide in the treatment of refractory acute nonlymphocytic leukemia with monocytic features.
Hurd DD; Peterson BA; McKenna RW; Bloomfield CD
Med Pediatr Oncol; 1981; 9(3):251-5. PubMed ID: 7017368
[TBL] [Abstract][Full Text] [Related]
9. Acute monocytic leukemia in children. Response to VP-16-213 as a single agent.
Nishikawa A; Nakamura Y; Nobori U; Aoki T; Higashino H; Matsui T; Kobayashi Y; Yamashita M; Unishi G
Cancer; 1987 Nov; 60(9):2146-9. PubMed ID: 3326651
[TBL] [Abstract][Full Text] [Related]
10. Podophyllotoxin derivative VP 16-213.
Arnold AM
Cancer Chemother Pharmacol; 1979; 3(2):71-80. PubMed ID: 389478
[TBL] [Abstract][Full Text] [Related]
11. Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia.
Whitlock JA; Greer JP; Lukens JN
Cancer; 1991 Aug; 68(3):600-4. PubMed ID: 1648435
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
